Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
DEER PARK, Ill., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, reported that its partner has not yet received a …